HRP921454A2 - Stable salts of (1r,2s)-2-n-(2-hydroxylamino-2-oxoethyl)-n-methyl-amino onyl cyclohexane-1-carboxylic acid, process for their aration and pharmaceutical compositions containing them - Google Patents

Stable salts of (1r,2s)-2-n-(2-hydroxylamino-2-oxoethyl)-n-methyl-amino onyl cyclohexane-1-carboxylic acid, process for their aration and pharmaceutical compositions containing them Download PDF

Info

Publication number
HRP921454A2
HRP921454A2 HR921454A HRP921454A HRP921454A2 HR P921454 A2 HRP921454 A2 HR P921454A2 HR 921454 A HR921454 A HR 921454A HR P921454 A HRP921454 A HR P921454A HR P921454 A2 HRP921454 A2 HR P921454A2
Authority
HR
Croatia
Prior art keywords
oxoethyl
cyclohexane
carboxylic acid
methylamino
carbonyl
Prior art date
Application number
HR921454A
Other languages
English (en)
Croatian (hr)
Inventor
Raffaello Giorgi
Alessandro Subissi
Luigi Turbanti
Original Assignee
Guidotti & C Spa Labor
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guidotti & C Spa Labor filed Critical Guidotti & C Spa Labor
Publication of HRP921454A2 publication Critical patent/HRP921454A2/hr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/26—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one amino group bound to the carbon skeleton, e.g. lysine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
HR921454A 1991-12-23 1992-12-22 Stable salts of (1r,2s)-2-n-(2-hydroxylamino-2-oxoethyl)-n-methyl-amino onyl cyclohexane-1-carboxylic acid, process for their aration and pharmaceutical compositions containing them HRP921454A2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI913448A IT1252708B (it) 1991-12-23 1991-12-23 Sali stabili dell'acido (+)-(1r,2s)-2((n-(2-idrossilammino-2-ossoetil)-n-metilammino)carbonil)cicloesan-1-carbossilico,ad attivita' ace inibitrice, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.

Publications (1)

Publication Number Publication Date
HRP921454A2 true HRP921454A2 (en) 1995-02-28

Family

ID=11361409

Family Applications (1)

Application Number Title Priority Date Filing Date
HR921454A HRP921454A2 (en) 1991-12-23 1992-12-22 Stable salts of (1r,2s)-2-n-(2-hydroxylamino-2-oxoethyl)-n-methyl-amino onyl cyclohexane-1-carboxylic acid, process for their aration and pharmaceutical compositions containing them

Country Status (26)

Country Link
EP (1) EP0575572A1 (pl)
JP (1) JPH06506002A (pl)
CN (1) CN1079474A (pl)
AU (1) AU657591B2 (pl)
BG (1) BG98050A (pl)
BR (1) BR9205652A (pl)
CA (1) CA2104372A1 (pl)
CZ (1) CZ379692A3 (pl)
EE (1) EE9400006A (pl)
FI (1) FI933685A0 (pl)
HR (1) HRP921454A2 (pl)
HU (1) HUT69287A (pl)
IT (1) IT1252708B (pl)
LV (1) LV10426B (pl)
MA (1) MA22749A1 (pl)
MX (1) MX9207543A (pl)
NZ (1) NZ245547A (pl)
PL (1) PL169086B1 (pl)
PT (1) PT101156A (pl)
RU (1) RU2079489C1 (pl)
SI (1) SI9200409A (pl)
SK (1) SK379692A3 (pl)
TN (1) TNSN92117A1 (pl)
WO (1) WO1993013056A1 (pl)
YU (1) YU110892A (pl)
ZA (1) ZA9210004B (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1264860B1 (it) * 1993-06-21 1996-10-17 Guidotti & C Spa Labor Derivati di acidi cis- e trans-2(((2-(isdrossiammino)-2-ossoetil)- alchilammino)carbonil)cicloesancarbossilici
US5639746A (en) * 1994-12-29 1997-06-17 The Procter & Gamble Company Hydroxamic acid-containing inhibitors of matrix metalloproteases
FR2817241B1 (fr) 2000-11-30 2003-03-07 Cebal Tube aluminium avec embout secable
CN101516191A (zh) * 2006-09-28 2009-08-26 默克公司 Saha的胺碱盐和其多晶型物
CN114845603B (zh) 2020-04-27 2025-01-24 卡特-霍夫曼有限责任公司 用于柜的门移动系统

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1224627B (it) * 1988-04-12 1990-10-04 Guidotti & C Spa Labor Ammidi di acidi ciclometilen_1,2_dicarbossilici adattivita' terapeutica, procedimenti per la loro preparazione e composizioni farmaceutiche che le contengono.

Also Published As

Publication number Publication date
JPH06506002A (ja) 1994-07-07
MX9207543A (es) 1993-08-01
AU657591B2 (en) 1995-03-16
AU3087192A (en) 1993-07-28
SI9200409A (en) 1993-09-30
CN1079474A (zh) 1993-12-15
ITMI913448A1 (it) 1993-06-23
RU2079489C1 (ru) 1997-05-20
MA22749A1 (fr) 1993-07-01
NZ245547A (en) 1995-12-21
LV10426B (en) 1995-08-20
FI933685L (fi) 1993-08-20
FI933685A7 (fi) 1993-08-20
CA2104372A1 (en) 1993-06-24
EP0575572A1 (en) 1993-12-29
ZA9210004B (en) 1993-12-13
PL297118A1 (en) 1993-09-06
HU9302389D0 (en) 1993-11-29
PT101156A (pt) 1994-06-30
SK379692A3 (en) 1995-04-12
FI933685A0 (fi) 1993-08-20
ITMI913448A0 (it) 1991-12-23
BG98050A (bg) 1994-04-29
BR9205652A (pt) 1994-05-03
WO1993013056A1 (en) 1993-07-08
LV10426A (lv) 1995-02-20
EE9400006A (et) 1995-12-15
CZ379692A3 (en) 1993-09-15
HUT69287A (en) 1995-09-28
IT1252708B (it) 1995-06-26
YU110892A (sh) 1996-01-08
PL169086B1 (pl) 1996-05-31
TNSN92117A1 (fr) 1993-06-08

Similar Documents

Publication Publication Date Title
Nishizawa et al. Synthesis and structure-activity relations of bestatin analogs, inhibitors of aminopeptidase B
Bernatowicz et al. 1H-Pyrazole-1-carboxamidine hydrochloride an attractive reagent for guanylation of amines and its application to peptide synthesis
Weber et al. Comparison of the photochemical behavior of four different photoactivatable probes
Hofmann et al. Studies on Polypeptides. VII. The Synthesis of Peptides Containing Arginine1
Wyvratt et al. Reductive amination of ethyl 2-oxo-4-phenylbutanoate with L-alanyl-L-proline. Synthesis of enalapril maleate
Szirtes et al. Synthesis of thyrotropin-releasing hormone analogs. 1. Complete dissociation of central nervous system effects from thyrotropin-releasing activity
Holley et al. The Synthesis of L-Histidyl Peptides1
RS63143B1 (sr) Jedinjenja
AU2023385357A1 (en) Process for preparing a gip/glp1 dual agonist
CN101959892A (zh) (r),(r)-2,2’-二-甲基纳曲酮的制备和用途
Bouchet et al. Aryl diazo compounds and diazonium salts as potential irreversible probes of the GABA receptor
Li et al. The Synthesis of L-Histidyl-L-phenylalanyl-L-ornithyl-L-tryptophyl-glycine and L-Histidyl-D-phenylalanyl-L-ornithyl-L-tryptophyl-glycine and their Melanocyte-stimulating Activity
Stark [29] Sequential degradation of peptides and proteins from their COOH termini with ammonium thiocyanate and acetic anhydride
Jain et al. Synthesis and biology of new thyrotropin-releasing hormone (TRH) analogues
RU2079489C1 (ru) Стабильные соли (+)-(1s,2r)-2[[n-(2-гидроксиамино-2-оксоэтил)-n-метиламино]-карбонил]циклогексан-1-карбоновой кислоты, способ их получения и фармацевтическая композиция
Poulos et al. Synthesis and biological activity of substance P C-terminal hexapeptide analogues: structure-activity studies
US20130143262A1 (en) Method for producing peptide
US3178472A (en) Preparation of optically active naturally occurring n-monomethyl-amino carboxylic acids
CN107629115A (zh) 一种特拉万星的纯化方法
US8013176B2 (en) Paricalcitol purification
JP2568635B2 (ja) 塩基性アミド化合物
EP1048674A1 (en) Method for separating and purifying aspartame and aspartame derivative
TW202504888A (zh) 苯丙胺酸類衍生物的拆分方法和中間體
HK1000209B (en) Reductive amination of an aminoacid or an aminoacid derivative with an alpha-keto acid or an alpha-keto acid derivative
Tesser et al. RESOLUTION OF DL‐PENTAMETHYLPHENYLALANINE

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
ODRP Renewal fee for the maintenance of a patent

Payment date: 19951222

Year of fee payment: 4

ODBC Application rejected